Literature DB >> 29655187

Classifying medical histories in US Medicare beneficiaries using fixed vs all-available look-back approaches.

Mitchell M Conover1, Til Stürmer1, Charles Poole1, Robert J Glynn2, Ross J Simpson3, Virginia Pate1, Michele Jonsson Funk1.   

Abstract

PURPOSE: Evaluate use of fixed and all-available look-backs to identify eligibility criteria and confounders among Medicare beneficiaries.
METHODS: We identified outpatient visits (2007-2012) with recently documented (≤180 days) cardiovascular risk and classified patients according to whether the exposure (statin) was initiated within 14 days. We selected each beneficiary's first eligible visit (in each treatment group) that met criteria during the respective look-backs: continuous enrollment (1 or 3 years for fixed look-back; 180 days for all-available), no cancer history, and no statin claims. We estimated crude and standardized mortality ratio weighted hazard ratios (HRs) for the effect of statin initiation on incident 6-month cancer (a known null effect) and 2-year mortality, separately, adjusting for covariates assessed by using each look-back.
RESULTS: Analyzing short-term cancer, the estimated HR from the all-available approach (HR = 0.90, 95% CI: 0.83, 0.98) was less biased than the 1-year look-back (HR = 0.79, 95% CI: 0.73, 0.84), which included beneficiaries with prevalent cancer. The 3-year look-back (HR = 1.05, 95% CI: 0.90, 1.21) was somewhat less biased than the all-available estimate but less precise due the exclusion of a large proportion of observations without sufficient continuous enrollment (62.0% and 59.9% of initiators and non-initiators, respectively). All approaches produced similar estimates of the effect on all-cause mortality. Alternative look-backs did not differ in their ability to control confounding.
CONCLUSIONS: The all-available look-back performed nearly as well as the 3-year fixed, which produced the least biased point estimate. If 3-year look-backs are infeasible (eg, due to power/sample), all-available look-backs may be preferable to short (1-year) fixed look-backs.
Copyright © 2018 John Wiley & Sons, Ltd.

Entities:  

Keywords:  administrative claims; bias; classification; confounding variables; database; epidemiologic methods; health care; longitudinal studies; pharmacoepidemiology

Mesh:

Substances:

Year:  2018        PMID: 29655187      PMCID: PMC6417795          DOI: 10.1002/pds.4435

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  19 in total

1.  Propensity score methods for confounding control in nonexperimental research.

Authors:  M Alan Brookhart; Richard Wyss; J Bradley Layton; Til Stürmer
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2013-09-10

2.  Analytic strategies to adjust confounding using exposure propensity scores and disease risk scores: nonsteroidal antiinflammatory drugs and short-term mortality in the elderly.

Authors:  Til Stürmer; Sebastian Schneeweiss; M Alan Brookhart; Kenneth J Rothman; Jerry Avorn; Robert J Glynn
Journal:  Am J Epidemiol       Date:  2005-05-01       Impact factor: 4.897

3.  Selection of controls in case-control studies. I. Principles.

Authors:  S Wacholder; J K McLaughlin; D T Silverman; J S Mandel
Journal:  Am J Epidemiol       Date:  1992-05-01       Impact factor: 4.897

4.  Toward a national framework for the secondary use of health data: an American Medical Informatics Association White Paper.

Authors:  Charles Safran; Meryl Bloomrosen; W Edward Hammond; Steven Labkoff; Suzanne Markel-Fox; Paul C Tang; Don E Detmer
Journal:  J Am Med Inform Assoc       Date:  2006-10-31       Impact factor: 4.497

5.  Statins and the risk of lung, breast, and colorectal cancer in the elderly.

Authors:  Soko Setoguchi; Robert J Glynn; Jerry Avorn; Helen Mogun; Sebastian Schneeweiss
Journal:  Circulation       Date:  2006-12-18       Impact factor: 29.690

6.  Developing the Sentinel System--a national resource for evidence development.

Authors:  Rachel E Behrman; Joshua S Benner; Jeffrey S Brown; Mark McClellan; Janet Woodcock; Richard Platt
Journal:  N Engl J Med       Date:  2011-01-12       Impact factor: 91.245

7.  Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): reduction in atherosclerosis progression and clinical events. PLAC I investigation.

Authors:  B Pitt; G B Mancini; S G Ellis; H S Rosman; J S Park; M E McGovern
Journal:  J Am Coll Cardiol       Date:  1995-11-01       Impact factor: 24.094

8.  Estimation using all available covariate information versus a fixed look-back window for dichotomous covariates.

Authors:  Steven M Brunelli; Joshua J Gagne; Krista F Huybrechts; Shirley V Wang; Amanda R Patrick; Kenneth J Rothman; John D Seeger
Journal:  Pharmacoepidemiol Drug Saf       Date:  2013-03-22       Impact factor: 2.890

9.  Competing risk regression models for epidemiologic data.

Authors:  Bryan Lau; Stephen R Cole; Stephen J Gange
Journal:  Am J Epidemiol       Date:  2009-06-03       Impact factor: 4.897

10.  Statins for secondary prevention in elderly patients: a hierarchical bayesian meta-analysis.

Authors:  Jonathan Afilalo; Gustavo Duque; Russell Steele; J Wouter Jukema; Anton J M de Craen; Mark J Eisenberg
Journal:  J Am Coll Cardiol       Date:  2008-01-01       Impact factor: 24.094

View more
  6 in total

1.  Comparative safety of high-dose versus standard-dose influenza vaccination in patients with end-stage renal disease.

Authors:  J Bradley Layton; Leah J McGrath; John M Sahrmann; Yinjiao Ma; Vikas R Dharnidharka; Caroline O'Neil; David J Weber; Anne M Butler
Journal:  Vaccine       Date:  2020-06-19       Impact factor: 3.641

2.  Measurement error and misclassification in electronic medical records: methods to mitigate bias.

Authors:  Jessica C Young; Mitchell M Conover; Michele Jonsson Funk
Journal:  Curr Epidemiol Rep       Date:  2018-09-10

3.  Considerations for observational study design: Comparing the evidence of opioid use between electronic health records and insurance claims.

Authors:  Jessica C Young; Nabarun Dasgupta; Til Stürmer; Virginia Pate; Michele Jonsson Funk
Journal:  Pharmacoepidemiol Drug Saf       Date:  2022-05-23       Impact factor: 2.732

4.  Association of Opioid Dose Reduction With Opioid Overdose and Opioid Use Disorder Among Patients Receiving High-Dose, Long-term Opioid Therapy in North Carolina.

Authors:  Bethany L DiPrete; Shabbar I Ranapurwala; Courtney N Maierhofer; Naoko Fulcher; Paul R Chelminski; Christopher L Ringwalt; Timothy J Ives; Nabarun Dasgupta; Vivian F Go; Brian W Pence
Journal:  JAMA Netw Open       Date:  2022-04-01

5.  A nationwide registry study on heart failure in Norway from 2008 to 2018: variations in lookback period affect incidence estimates.

Authors:  Kristina Malene Ødegaard; Sandre Svatun Lirhus; Hans Olav Melberg; Jonas Hallén; Sigrun Halvorsen
Journal:  BMC Cardiovasc Disord       Date:  2022-03-05       Impact factor: 2.298

6.  Association of the Timing of Postpartum Intrauterine Device Insertion and Breastfeeding With Risks of Intrauterine Device Expulsion.

Authors:  Mary Anne Armstrong; Tina Raine-Bennett; Susan D Reed; Jennifer Gatz; Darios Getahun; Juliane Schoendorf; Debbie Postlethwaite; Michael J Fassett; Jeffrey F Peipert; Catherine W Saltus; Maqdooda Merchant; Amy Alabaster; Xiaolei Zhou; Laura Ichikawa; Jiaxiao M Shi; Vicki Y Chiu; Fagen Xie; Shannon Hunter; Jinyi Wang; Mary E Ritchey; Giulia Chillemi; Theresa M Im; Harpreet S Takhar; Federica Pisa; Alex Asiimwe; Mary S Anthony
Journal:  JAMA Netw Open       Date:  2022-02-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.